Evidence map›Paper›PMID 42220783›Full record

ArticleCureus2026

Umbilical Cord Mesenchymal Stem Cell-Derived Exosome-Mediated Regeneration in Hypertrophic Burn Scars Treated With Dual-Wavelength Laser: A Case Report.

Ruri Pamela, Chi-Chih Kang, Lenny Lien, Grace Lee, Kyuho Yi

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ruri PamelaDermatology, Venereology and Aesthetic General Soedirman National Defense Central Hospital, Jakarta, IDN.
Chi-Chih KangProject Management, BIONET Therapeutics, Taipei, TWN.
Lenny LienMedicine, BIONET Therapeutics, Taipei, TWN.
Grace LeeExecutive Office, BIONET Therapeutics, Taipei, TWN.
Kyuho YiAnatomy, Yonsei University, Seoul, KOR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypertrophic scarring following second-degree thermal injuries presents significant functional and cosmetic burdens, often characterized by dysregulated collagen deposition and persistent inflammation. Emerging multimodal treatment protocols involving the combination of regenerative medicine and non-ablative laser treatments offer novel scar management potential. We report the case of a 46-year-old woman presenting with a symptomatic hypertrophic scar resulting from a thermal injury sustained one month prior. The patient underwent a combined treatment protocol consisting of two sessions of fractional laser treatment (1550 + 577 nm), immediately followed by the application of umbilical cord mesenchymal stem cell (UCMSC)-derived exosomes via microneedling. Following two treatment courses, the patient demonstrated significant clinical improvement, characterized by a marked reduction in pigmentation, decreased erythema, and improved tissue pliability. This observed treatment efficacy is likely attributed to the synergistic effect of the ability of fractional lasers to create photothermolysis for remodeling fibrotic tissues, and the regenerative ability of UCMSC-exosomes to mitigate local inflammation and promote a controlled wound healing process. This case highlights the treatment potential of a multimodal protocol for managing hypertrophic burn scars. Further prospective, controlled studies are necessary to determine if exosome integration offers a definitive clinical advantage over energy-based monotherapies and to establish standardized treatment parameters.

Indexed as

exosomehypertrophic burn scarmesenchymal stem cellmicroneedlingnon-ablative fractional lasertissue regenerationumbilical cord

Identifiers

PMID42220783
PMCPMC13218783

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.